Chronic myelogenous leukemia (CML) is usually diagnosed in the chronic phase. Untreated
chronic phase CML will eventually progress to advanced phase (accelerated or blast phase) …

The introduction of tyrosine kinase inhibitors (TKIs) has fundamentally changed the
management of chronic myeloid leukemia (CML). Disease progression to advanced phase …

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
resulting from a reciprocal translocation between chromosomes 9 and 22 [t9; 22] that gives …

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …

The management of chronic myeloid leukemia (CML) in accelerated or blast phase
(advanced phase) remains a significant challenge despite the introduction of very effective …

Opinion statement Discovery of targeted BCR-ABL protein tyrosine kinase inhibitors (TKI) in
the therapy of patients with chronic myeloid leukemia (CML) is perhaps the most popular …

The prognosis of chronic phase chronic myeloid leukemia (CML) has improved so that life
expectancy for patients responding to tyrosine kinase inhibitors (TKIs) is now equivalent to …

Management of chronic myeloid leukemia (CML) in advanced phases remains a challenge
also in the era of tyrosine kinase inhibitors (TKIs) treatment. Cytogenetic clonal evolution …

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …

The NCCN Guidelines for Chronic Myeloid Leukemia (CML) criteria for discontinuation of
tyrosine kinase inhibitor (TKI) therapy have not seen significant updates in the past year, but …